Follow The Filings

LLYVA

Consumer Discretionary, filed as LIBERTY LIVE HOLDINGS INC (COM SER A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 2 managers in 2026 Q2

  • 4 Owners
  • Max 3.1%
  • $686M
  • 2 reduce

In 2026 Q2 ValueAct Capital and Murray Stahl trimmed LLYVA.

Who owns this now

Largest portfolio weights among holders, up to 3.1% (Corvex Management). Not free-float ownership.

  1. Corvex Management 3.1%
  2. Valueact Capital Reduce 1.4%
  3. Warren Buffett 0.17%

Who owns LLYVA

Sorted by value, long equity only, as of 2026 Q2.

History
Warren Buffett, Berkshire Hathaway 0.17% Hold 4,986,588 $505M History
Corvex Management 3.1% Hold 1,005,434 $102M History
Valueact Capital, Valueact Holdings 1.4%, was 2.8% Reduce −55.8% 785,119 $80M History
Murray Stahl, Horizon Kinetics Asset Management <0.01% Reduce −7.0% 2,134 $216K History

4 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by LLYVA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LLYVA insider trades
  • $2.9M bought by 1 insider
  • $30.3M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. John C Malone 10% owner
    Buy
    $2.9M 28,333 shares at $102.53 +1.2% to stake
    Traded Sep 24 Filed Sep 28
    ↗
  2. John C Malone 10% owner
    Sale
    $2.9M 29,593 shares at $98.16 0.9% of stake
    Traded Sep 24 Filed Sep 28
    ↗
  3. Berkshire Hathaway Inc. 10% owner, +1 joint filer
    Sale
    $27.4M 330,518 shares at $82.86 3% of stake
    Traded Jan 6–16 Filed Feb 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 25 other transactions, 3 stock grants, and 3 share withholdings for taxes.

Congress

1 member of Congress traded LLYVA in the last three years: 0 buys and 0 sales. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Thomas H. Kean, Jr. R-NJ-7 Exchange $1K–$15K Dec 16, 2025 filed Jan 16

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.03,9.01 Filing Doc
SCHEDULE 13D — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2025
Revenue $381.95M
Gross profit * $73.52M
Gross margin * 19.2%
Net income -$86.97M
Net margin * -22.8%

Balance sheet

Metric FY2025
Total current assets $629.46M
Total non-current assets * $1.26B
Total assets $1.89B
Total current liabilities $1.9B
Total non-current liabilities * $19.31M
Total equity -$49.08M

Cash flow

Metric FY2025
Cash from operations -$29.46M
Cash from investing -$3.48M
Cash from financing $167.76M
Net change in cash $135.99M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.